Peter A. Sims

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses

  Nature Communications · 2026-06-25

• 44. A Pipeline for Drug Repurposing Identifies Topoisomerase-I Inhibition as a Potent Regulator of Human Microglial Phagocytosis and Metabolism; Extensions to Psychiatric Pharmacology

  Biological Psychiatry · 2026-04-25

• 59831 Convection-Enhanced Delivery of Topotecan Induces IL-1β-Associated Inflammation in Glioblastoma

  Neurosurgery · 2026-03-26

• Visualization and quantification of rDNA instabilities in mammalian cells and mouse models

  Nucleic Acids Research · 2025-12-27

• TMPO promotes cellular dissemination and metastasis in circulating tumor cells

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-27

• Tissue signatures of human macrophages during homeostasis and activation

  The Journal of Immunology · 2025-12-12

• Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• TMIC-111. Intraoperative 5-Aminolevulinic Acid (5ALA) fluorescence distinguishes cellular composition and immunogenicity in the infiltrating margin of Glioblastoma

  Neuro-Oncology · 2025-11-01

• TMET-43. IDH1(R132H) inhibitors enhance the sensitivity of IDH1-mutant glioma to cysteine deprivation and ferroptosis

  Neuro-Oncology · 2025-11-01 · 1 citations

• A lymph node slice culture model to spatially profile early vaccine responses in human tissue 3287

  The Journal of Immunology · 2025-11-01

• DDDR-56. Single-cell analysis of drug perturbations in IDH-mutant glioma

  Neuro-Oncology · 2025-11-01